Form 4: Jazz Pharma EVP Acquires Shares, Covers Taxes

Jazz Pharmaceuticals plc's EVP & Chief Legal Officer, Neena M Patil, reported the acquisition of 8,852 ordinary shares from performance awards and the disposition of 3,275 shares for tax obligations.

Summary

• Neena M Patil, EVP & Chief Legal Officer of Jazz Pharmaceuticals plc, reported changes in her beneficial ownership.
• On January 16, 2026, 8,852 ordinary shares were delivered to Ms. Patil following the satisfaction of performance-based vesting requirements for awards made on March 3, 2023.
• Concurrently, 3,275 ordinary shares were disposed of at a price of $171.16 per share to cover tax obligations related to the vesting of these performance share awards.
• Ms. Patil also acquired 116 ordinary shares on May 30, 2025, and 120 ordinary shares on November 28, 2025, through a Section 423 Employee Stock Purchase Plan.
• Following these transactions, Ms. Patil directly beneficially owns 53,339 ordinary shares.

Sentiment

Score: 6

Explanation: The filing reports routine insider transactions, including the vesting of performance awards and tax-related dispositions, alongside minor employee stock plan purchases. The vesting of performance awards is generally a positive indicator of goal achievement, while tax withholding is a neutral, administrative event. The overall sentiment is mildly positive due to the successful vesting and continued insider investment through ESPP, but it's a factual report with limited broader implications.

Positives

• Vesting of 8,852 performance share awards indicates the achievement of previously set performance targets.
• Acquisition of 236 ordinary shares (116 + 120) through the Employee Stock Purchase Plan demonstrates continued investment by the executive in the company.

Negatives

• Disposition of 3,275 shares was solely for tax obligations related to the vesting of performance awards, which is a routine and non-discretionary event.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing (Form 4) and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: Provides transparency on executive share ownership and compensation structure. The vesting of performance shares indicates management met certain targets, which could be viewed positively.
• Employees: The Employee Stock Purchase Plan (ESPP) participation highlights an avenue for employees to invest in the company.

Key Dates

Keywords

Jazz Pharmaceuticals, JAZZ, SEC Form 4, Insider Trading, Beneficial Ownership, Performance Shares, Employee Stock Purchase Plan, Executive Compensation, Neena M Patil